Alcon has appointed Mohinder (Mo) Merchea, OD, PhD, MBA as Head of Medical Affairs for Vision Care in the US and Canada. In his new role for Alcon, Dr. Merchea will develop strategic scientific plans for brands in the Vision Care franchise, with a focus on the needs of patients, the medical and scientific communities and regulatory authorities. Dr. Merchea will lead regional strategy for Phase IIIb and Phase IV trials in the US and Canada.

In addition to contributing to medical communication, publication and key conference plans, Dr. Merchea will oversee independent medical education programs for Alcon's clinician partners. Dr. Merchea brings more than 18 years of experience in eye health, clinical research and medical device development. His clinical expertise includes refractive surgery, keratoconus, topography, wavefront aberrations, ocular surface and contact lenses, and lens care solutions.

Dr. Merchea concluded a 12-year career at Bausch + Lomb, a division of Valeant Pharmaceuticals Inc. as the head of medical affairs, Vision Care and most recently with LENSAR Inc.